Nuvalent
Shashank Kulkarni is a seasoned professional in medicinal chemistry with extensive experience in the pharmaceutical industry. Currently serving as Principal Scientist at Nuvalent, Inc. since January 2022, Shashank has previously held roles at EMD Serono, Inc. from January 2017 to January 2022, including Senior Scientist and various research positions. Earlier experience includes valuable contributions as a Research Assistant at the Center for Drug Discovery and the Arkansas Biosciences Institute. Shashank holds a Doctor of Philosophy in Medicinal Chemistry and Drug Discovery from Northeastern University, a Master of Science in Biochemistry from Arkansas State University, and a Bachelor of Science in Chemistry from Alcorn State University.
This person is not in the org chart
This person is not in any teams
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.